MYP_148646
Basic Information
Unnamed
Anticancer
Immunology Immunomodulation Immunogenic
Standard
11 amino acids
C48H79N11O13S
Standard
Sequence
SLIAAAAFCLA
Physicochemical Analysis
1050.27 Da
5.24
-0.55
-0.77
-0.0500
2.33
0.14
0.72
26.60
151.82
0.0909
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
374.55
-2.35
14.0
14.0
31.0
73.0
1.0
10.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0112837 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Tumor-associated antigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer Immunogenic
acute myeloid leukemia (AML); HLA-A*02:01
51Cr release
RECORD: Rec_0310125 VERIFIED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Tumor-associated antigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer
acute myeloid leukemia (AML); HLA-A*02:01
0.33187 μM
Predicted HLA-I binding
RECORD: Rec_0386309 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Tumor-associated antigen
9606
Structure & Mods
linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Anticancer Immunogenic
acute myeloid leukemia (AML); HLA-A*02:01
Intracellular cytokine staining (ICS)